Endocrinology, Vol 135, 1025-1031, Copyright © 1994 by Endocrine Society

ARTICLES

Analysis of human and rodent beta 3-adrenergic receptor messenger ribonucleic acids

JG Granneman and KN Lahners
Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan 48201.

Recent evidence indicates that the human and rodent beta 3-receptor genes differ with respect to their intron/exon organization and putative regulatory elements in the proximal promotor regions. The present work examined the molecular basis for heterogeneity among human and rodent beta 3-receptor messenger RNAs (mRNAs) and mRNA transcription start site selection with gene-derived human and rodent probes. This analysis indicates that the mRNA size heterogeneity of the human beta 3-receptor mRNA seen in Northern blots results from the use of alternative polyadenylation signals. In contrast, mRNA heterogeneity of the rat beta 3-receptor mRNA is due to the use of widely separated promoters. Analysis of mRNA transcription sites within the proximal promoters of the human and rat genes indicates that multiple homologous start sites are used. However, the pattern of transcription initiation appears to be both species and tissue specific. In rat adipose tissues where abundant expression of the beta 3 gene occurs, most transcripts began at -161 relative to translation initiation ATG, whereas minor transcription began around -123 and -109. Interestingly, virtually all transcripts were found to begin at the -123 and -109 sites in the rat gastric fundus, which expresses only low levels of beta 3-receptor mRNA. In human brown fat and neuroepithelioma cells, the vast majority (> 80%) of beta 3 transcripts began at multiple sites around -130. Exposure of murine 3T3-F442A adipocytes to isoproterenol, 8-bromo-cAMP, phorbol 12-myristate 13-acetate, or dexamethasone dramatically reduced murine beta 3-receptor mRNA levels. In contrast to mouse adipocytes, 8- bromo-cAMP increased human beta 3-receptor mRNA levels in SK-N-MC neuroepithelioma cells, whereas isoproterenol, phorbol 12-myristate 13- acetate, and dexamethasone were without effect. These data identify important differences in the structure and regulation of the human and rodent beta 3-receptor genes and suggest that the data obtained in rodent models may not be directly applicable to the regulation of the human gene.

This article has been cited by other articles:

				J. G. Nickerson, S. G. Dugan, G. Drouin, S. F. Perry, and T. W. Moon Activity of the unique {beta}-adrenergic Na+/H+ exchanger in trout erythrocytes is controlled by a novel {beta}3-AR subtype Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R526 - R535. [Abstract] [Full Text] [PDF]

				H. K. Takahashi, T. Morichika, H. Iwagaki, T. Yoshino, R. Tamura, S. Saito, S. Mori, T. Akagi, N. Tanaka, and M. Nishibori Effect of {beta}2-Adrenergic Receptor Stimulation on Interleukin-18-Induced Intercellular Adhesion Molecule-1 Expression and Cytokine Production J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 634 - 642. [Abstract] [Full Text] [PDF]

				S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF]

				V. S. Susulic, L. LaVallette, E. Duzic, L. Chen, D. Shuey, S. K. Karathanasis, and K. E. Steiner Expression of the Human {beta}3-Adrenergic Receptor Gene in SK-N-MC Cells Is Under the Control of a Distal Enhancer Endocrinology, May 1, 2001; 142(5): 1935 - 1949. [Abstract] [Full Text]

				P. M. Watson, S. P. Commins, R. J. Beiler, H. C. Hatcher, and T. W. Gettys Differential regulation of leptin expression and function in A/J vs. C57BL/6J mice during diet-induced obesity Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E356 - E365. [Abstract] [Full Text] [PDF]

				M. R. Candelore, L. Deng, L. Tota, X.-M. Guan, A. Amend, Y. Liu, R. Newbold, M. A. Cascieri, and A. E. Weber Potent and Selective Human beta 3-Adrenergic Receptor Antagonists J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 649 - 655. [Abstract] [Full Text]

				S. P. Commins, P. M. Watson, M. A. Padgett, A. Dudley, G. Argyropoulos, and T. W. Gettys Induction of Uncoupling Protein Expression in Brown and White Adipose Tissue by Leptin Endocrinology, January 1, 1999; 140(1): 292 - 300. [Abstract] [Full Text]

				K. E. Hadri, A. Courtalon, X. Gauthereau, A.-M. Chambaut-Guerin, J. Pairault, and B. Feve Differential Regulation by Tumor Necrosis Factor-alpha of beta 1-, beta 2-, and beta 3-Adrenoreceptor Gene Expression in 3T3-F442A Adipocytes J. Biol. Chem., September 26, 1997; 272(39): 24514 - 24521. [Abstract] [Full Text] [PDF]

				D. Grujic, V. S. Susulic, M.-E. Harper, J. Himms-Hagen, B. A. Cunningham, B. E. Corkey, and B. B. Lowell beta 3-Adrenergic Receptors on White and Brown Adipocytes Mediate beta 3-Selective Agonist-induced Effects on Energy Expenditure, Insulin Secretion, and Food Intake. A STUDY USING TRANSGENIC AND GENE KNOCKOUT MICE J. Biol. Chem., July 11, 1997; 272(28): 17686 - 17693. [Abstract] [Full Text] [PDF]

				T. Bengtsson, K. Redegren, A. D. Strosberg, J. Nedergaard, and B. Cannon Down-regulation of beta 3 Adrenoreceptor Gene Expression in Brown Fat Cells Is Transient and Recovery Is Dependent upon a Short-lived Protein Factor J. Biol. Chem., December 27, 1996; 271(52): 33366 - 33375. [Abstract] [Full Text] [PDF]

				B. G. Tholanikunnel, J. G. Granneman, and C. C. Malbon The M[IMAGE] 35,000 [IMAGE]-Adrenergic Receptor mRNA-binding Protein Binds Transcripts of G-protein-linked Receptors Which Undergo Agonist-induced Destabilization J. Biol. Chem., May 26, 1995; 270(21): 12787 - 12793. [Abstract] [Full Text] [PDF]

				B. Fève, F. Piétri-Rouxel, K. E. Hadri, M.-F. Drumare, and A. D. Strosberg Long Term Phorbol Ester Treatment Down-regulates the [IMAGE][IMAGE]-Adrenergic Receptor in 3T3-F442A Adipocytes J. Biol. Chem., May 5, 1995; 270(18): 10952 - 10959. [Abstract] [Full Text] [PDF]